article thumbnail

A backpack full of multiple sclerosis therapy

World Pharma News

Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing patients' ability to move and function to progressively decline. Alarmingly, since 2013, the world-wide prevalence of MS has risen by 30%.

article thumbnail

Brand Name Search

RX Note

However, with the proliferation of biosimilars and liposomal or pegylated forms, health care professionals are now encouraged to communicate using product name for certain circumstances (e.g. Few years back, doctors are urged to prescribe drugs by active ingredients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Creative agency woolley pau regains independence after buyout

pharmaphorum

Shorthose, Christian Dawson and Dean Woolley bought out the agency, which was had previously been acquired by healthcare communications company gyro in 2007 and then in 2016 by digital marketing company Dentsu Aegis Network. Ed Shorthose, managing director, said the move “felt right on every level”.

article thumbnail

Health Innovators: Healios’ Richard Andrews

pharmaphorum

In 2013, he founded Healios to tackle the global inequality of healthcare provision affecting over one billion people worldwide with mental health and neurodevelopmental conditions. Prior to this, he founded pharmaphorum in 2009, which was acquired by Healthware Group in June 2020.

article thumbnail

NHS Digital, NHSX will be absorbed into NHS England

pharmaphorum

NHS Digital has been around rather longer – since 2013 – but has come under fire in the last few months over its controversial data sharing plan, which was placed on hold in the summer after more than a million people opted out of the scheme in the space of a few weeks.

article thumbnail

Teva faces EU antitrust probe over MS drug Copaxone

pharmaphorum

billion in annual sales it generated during its peak year in 2013. The Commission will also examine whether Teva may have launched a communication campaign to create a “false perception” about the health risks of prescribing generic competitors, aimed at healthcare professionals and hospitals.

article thumbnail

NHS patient data upload delayed by two months, says UK

pharmaphorum

People can opt out of the scheme by filling in a form and taking it to their GP, but campaigners have complained that this was not communicated effectively and could place an onerous workload on GPs already battling to provide care amid the pandemic.